Geez…take off the boxing gloves! We can talk about this like adults, can’t we? It’s just aspirin for primary prevention of cardiovascular disease! Although perhaps saying it’s “just” aspirin doesn’t quite encompass all the drama… I guess we should explain further in this literature-filled post about good old aspirin.
Read MoreWe’re back with round 2 of clinical trial updates! And this time, we’re tackling the world of infectious diseases. Come investigate what the most recent literature says about topics like sepsis, bacteremia, and cellulitis, and hone your AST brain!
Read MoreIf you thought learning Chemo Man was all the oncology you’d ever need, guess what…there’s more! Whether you practice (or want to practice) in oncology or you’re in general medicine, baseline knowledge of tumor lysis syndrome is essential. Let tl;dr give you the scoop on this explosive, gotta-know topic!
Read MoreIt’s the dreaded question about crushing that tablet. Of course, the answer’s not in the package insert, so what are YOU supposed to do? Guess what, tl;dr is here with some clues about how to figure out if and when it just might be ok to bend the crushing rules (or not).
Read MorePC…PCS…PCSK9 inhibitors! Yes, there are a lot of letters, and we ALL have a hard time keeping them in the right order. But why is this class of medications popping up more and more, and why should we FINALLY learn to keep the letters straight? For those times when maybe statins aren’t The Answer to Everything, we’re here with the rundown on this novel class of medications that you may have missed since pharmacy school!
Read MoreIf you learned that migraine management begins and ends with triptans (and maybe you got lost trying to keep all of those meds straight), you’re in for a treat! It’s not too often the pharmacy world gets to talk about an entirely new class of medications, but today is that day. It’s time to chat about CGRP inhibitors!
Read MoreYou went to class. You memorized all those guidelines. You figured you were good to go for a while, right? Maaaybe, but more than likely there’s new published info since you took those tests! Let tl;dr give you a heads up on some of the biggest therapeutic breakthroughs of the last couple months. And don’t worry - you CAN teach an old dog new tricks!
Read MoreYou’ve heard about them in the news. Now get up to speed with biosimilars and what they mean to your practice. Are they just like “generics?” Find out here.
Read MoreAfter a brief break from the liver, tl;dr is back with yet a few more complications of cirrhosis (the maze of liver effects continues!). In this installment, learn about hepatic encephalopathy and variceal bleeding with a little help from everyone’s favorite hobbit.
Read MoreASHP’s Midyear Meeting is right around the corner, and many of you are feeling the pressure of The Decision: should you pursue a pharmacy residency? In order to help you make the most informed choice, tl;dr is here with a couple additional facts and figures for you to weigh when considering all possibilities.
Read MoreA-CHOO!! Bless you. It’s that time of year again, folks. Let tl;dr help you with every runny nose, watery eye, and exploding head that walks through the pharmacy front door. Plus, bonus, we’re gonna talk about BMs!
Read MoreIt’s often easy for us to see cause and effect with medications for blood pressure or infections. But what about when the drug action isn’t so immediate and defined? How do we navigate those medications? This post is all about giving you the foundation for determining defining characteristics of a somewhat less black and white class of medications.
Read More